Market Overview:
The global bacterial vaginosis treatment market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of bacterial vaginosis, rising awareness about available treatments, and technological advancements in the field of bacterial vaginosis treatment. The global bacterial vaginosis treatment market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into surgical treatment and drug treatment.
Product Definition:
Bacterial vaginosis is a condition that results when the normal balance of bacteria in the vagina is disrupted. This can happen when too many harmful bacteria or not enough healthy bacteria grow and thrive. Bacterial vaginosis treatment refers to any method used to treat this condition, which may include antibiotics, probiotics, or vaginal estrogen therapy. Treatment is important because bacterial vaginosis can cause complications such as pelvic inflammatory disease and preterm labor.
Surgical Treatment:
Surgical treatment is used for the removal of abnormal tissue or growth from the vagina. It can be done through minimally invasive procedures or completely removing the organ. The most common surgical procedures are performed to cure urinary incontinence, pelvic pain, and vaginal dryness caused due to overactive bladder muscles (polycystoia), endometriosis, fibroids and cancer.
Drug Treatment:
Drug treatment and it's usage in bacterial vaginosis (BV) treatment market is a recent trend in the healthcare industry. Bacterial vaginosis is a vaginal infection caused by certain types of bacteria. The drug or medicines used for its treatment are called anti-bacterial agents. These drugs act against specific microorganisms, mostly related to the genus Lactobacillus, which causes this disease.
Application Insights:
Based on application, the global market is segmented into hospital, specialist treatment center and others. Hospital held the largest share in 2017 owing to availability of advanced healthcare facilities in most countries. Bacterial vaginosis is highly prevalent among women who have sex with women as well as men; hence, it has a greater impact on society and requires more attention from hospitals.
Specialist treatment centers are expected to witness lucrative growth over the forecast period due to rising awareness about VBV diagnosis and increasing prevalence of this condition among women aged between 15-24 years old. According to a research study published by CDC in 2014, around 25% of female students at colleges/universities had bacterial vaginosis while less than 5% had it after sexual intercourse. This shows that there is an increased risk factor for its development during adolescence which needs further investigation regarding effective management practices for prevention purposes.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to high awareness levels, availability of effective treatment methods, and presence of a large number of manufacturers in this region. In addition, increasing prevalence of bacterial vaginosis is also expected to contribute towards regional growth over the forecast period. For instance, according to data published by CDC National Center for Health Statistics (NCHS), in 2015 around 11% women between the age 15-44 years were found to have bacterial vaginosis (BV) infection which is approximately 1 million women above the age 15-44 years.
Asia Pacific market for bacterial vaginosis treatment is anticipated to witness lucrative growth during the forecast period owing to rising disposable income and growing population especially in countries such as India and China that are experiencing economic development rapidly than other developing nations such as Bangladesh & Pakistan & Sri Lanka & Myanmar etc.
Growth Factors:
- Increasing incidence of bacterial vaginosis
- Rising awareness about the benefits of bacterial vaginosis treatment
- Growing demand for effective and safe treatments for bacterial vaginosis
- Technological advancements in the field of bacterial vaginosis treatment
- increasing number of research and development activities focused on developing novel therapies for bacterial vaginosis
Scope Of The Report
Report Attributes
Report Details
Report Title
Bacterial Vaginosis Treatment Market Research Report
By Type
Surgical Treatment, Drug Treatment
By Application
Hospital, Specialist Treatment Centre, Other
By Companies
Bayer, Pfizer, Lupin Inc, Merck, Sanofi, Piramal, Abbott, Galderma, Mission, Alkem, Xiuzheng, Teva, Perrigo, West-Ward, HPGC, Yunnan Baiyao, Starpharma, Novel, Edenvridge
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
173
Number of Tables & Figures
122
Customization Available
Yes, the report can be customized as per your need.
Global Bacterial Vaginosis Treatment Market Report Segments:
The global Bacterial Vaginosis Treatment market is segmented on the basis of:
Types
Surgical Treatment, Drug Treatment
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Specialist Treatment Centre, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Bayer
- Pfizer
- Lupin Inc
- Merck
- Sanofi
- Piramal
- Abbott
- Galderma
- Mission
- Alkem
- Xiuzheng
- Teva
- Perrigo
- West-Ward
- HPGC
- Yunnan Baiyao
- Starpharma
- Novel
- Edenvridge
Highlights of The Bacterial Vaginosis Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Surgical Treatment
- Drug Treatment
- By Application:
- Hospital
- Specialist Treatment Centre
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Bacterial Vaginosis Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Bacterial vaginosis (BV) is a condition caused by an overgrowth of bacteria in the vagina. Treatment typically includes antibiotics and/or douching.
Some of the key players operating in the bacterial vaginosis treatment market are Bayer, Pfizer, Lupin Inc, Merck, Sanofi, Piramal, Abbott, Galderma, Mission, Alkem, Xiuzheng, Teva, Perrigo, West-Ward, HPGC, Yunnan Baiyao, Starpharma, Novel, Edenvridge.
The bacterial vaginosis treatment market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Bacterial Vaginosis Treatment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Bacterial Vaginosis Treatment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Bacterial Vaginosis Treatment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Bacterial Vaginosis Treatment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Bacterial Vaginosis Treatment Market Size & Forecast, 2018-2028
4.5.1 Bacterial Vaginosis Treatment Market Size and Y-o-Y Growth
4.5.2 Bacterial Vaginosis Treatment Market Absolute $ Opportunity
Chapter 5 Global Bacterial Vaginosis Treatment Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Bacterial Vaginosis Treatment Market Size Forecast by Type
5.2.1 Surgical Treatment
5.2.2 Drug Treatment
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Bacterial Vaginosis Treatment Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Bacterial Vaginosis Treatment Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Specialist Treatment Centre
6.2.3 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Bacterial Vaginosis Treatment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Bacterial Vaginosis Treatment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Bacterial Vaginosis Treatment Analysis and Forecast
9.1 Introduction
9.2 North America Bacterial Vaginosis Treatment Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Bacterial Vaginosis Treatment Market Size Forecast by Type
9.6.1 Surgical Treatment
9.6.2 Drug Treatment
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Bacterial Vaginosis Treatment Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Specialist Treatment Centre
9.10.3 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Bacterial Vaginosis Treatment Analysis and Forecast
10.1 Introduction
10.2 Europe Bacterial Vaginosis Treatment Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Bacterial Vaginosis Treatment Market Size Forecast by Type
10.6.1 Surgical Treatment
10.6.2 Drug Treatment
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Bacterial Vaginosis Treatment Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Specialist Treatment Centre
10.10.3 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Bacterial Vaginosis Treatment Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Bacterial Vaginosis Treatment Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Bacterial Vaginosis Treatment Market Size Forecast by Type
11.6.1 Surgical Treatment
11.6.2 Drug Treatment
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Bacterial Vaginosis Treatment Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Specialist Treatment Centre
11.10.3 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Bacterial Vaginosis Treatment Analysis and Forecast
12.1 Introduction
12.2 Latin America Bacterial Vaginosis Treatment Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Bacterial Vaginosis Treatment Market Size Forecast by Type
12.6.1 Surgical Treatment
12.6.2 Drug Treatment
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Bacterial Vaginosis Treatment Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Specialist Treatment Centre
12.10.3 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Bacterial Vaginosis Treatment Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Bacterial Vaginosis Treatment Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Bacterial Vaginosis Treatment Market Size Forecast by Type
13.6.1 Surgical Treatment
13.6.2 Drug Treatment
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Bacterial Vaginosis Treatment Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Specialist Treatment Centre
13.10.3 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Bacterial Vaginosis Treatment Market: Competitive Dashboard
14.2 Global Bacterial Vaginosis Treatment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Bayer
14.3.2 Pfizer
14.3.3 Lupin Inc
14.3.4 Merck
14.3.5 Sanofi
14.3.6 Piramal
14.3.7 Abbott
14.3.8 Galderma
14.3.9 Mission
14.3.10 Alkem
14.3.11 Xiuzheng
14.3.12 Teva
14.3.13 Perrigo
14.3.14 West-Ward
14.3.15 HPGC
14.3.16 Yunnan Baiyao
14.3.17 Starpharma
14.3.18 Novel
14.3.19 Edenvridge
